CIK 0001429260
- Non-accelerated filer
- Smaller reporting company
Fortress Biotech, Inc.
Sign in to watch- Ticker
- FBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 205157386
- Phone
- +1 781-652-4500
- Business address
- 1111 KANE CONCOURSE, SUITE 301, BAY HARBOR ISLANDS, FL, 33154
- Former names
- Fortress Biotech, Inc., CORONADO BIOSCIENCES INC
Securities
- FBIO Common Stock Nasdaq
- FBIOP 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 47 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-06-03 | Hunter Robyn Chief Financial Officer | Purchase | +2,297 | $1.10 | $3K | 220,619 |
| 2019-04-17 | Avgerinos George SVP, BIOLOGICS OPERATIONS | Grant or award · Options to purchase Common Stock | +200,000 | 200,000 | ||
| 2019-01-01 | WEISS MICHAEL S EXECUTIVE VICE CHAIRMAN | Grant or award | +648,204 | 9,400,275 | ||
| 2019-01-01 | Klein Dov Director | Grant or award | +100,000 | 455,000 | ||
| 2019-01-01 | ROSENWALD LINDSAY A MD PRESIDENT AND CEO | Grant or award | +648,204 | 8,172,897 | ||
| 2019-01-01 | LOBELL J JAY Director | Grant or award | +100,000 | 936,000 | ||
| 2019-01-01 | Hoenlein Malcolm Director | Grant or award | +50,000 | 335,000 | ||
| 2019-01-01 | Harvey Jimmie Director | Grant or award | +100,000 | 550,000 | ||
| 2019-01-01 | Rowinsky Eric K Director | Grant or award | +100,000 | 550,000 | ||
| 2018-12-11 | Avgerinos George SVP, BIOLOGICS OPERATIONS | Grant or award | +400,000 | 655,170 | ||
| 2018-12-11 | Avgerinos George SVP, BIOLOGICS OPERATIONS | Sale | −97,325 | $1.05 | $102K | 255,170 |
| 2018-12-01 | ROSENWALD LINDSAY A MD PRESIDENT AND CEO | Grant or award | +1,514 | 7,524,693 | ||
| 2018-11-23 | Hunter Robyn Chief Financial Officer | Sale | −20,370 | $1.29 | $26K | 239,759 |
| 2018-07-03 | WEISS MICHAEL S EXECUTIVE VICE CHAIRMAN | Grant or award | +164,473 | 8,752,071 | ||
| 2018-07-03 | ROSENWALD LINDSAY A MD PRESIDENT AND CEO | Grant or award | +164,473 | 7,523,179 | ||
| 2018-01-01 | WEISS MICHAEL S EXECUTIVE VICE CHAIRMAN | Grant or award | +586,428 | 8,587,598 | ||
| 2018-01-01 | Klein Dov Director | Grant or award | +100,000 | 355,000 | ||
| 2018-01-01 | ROSENWALD LINDSAY A MD PRESIDENT AND CEO | Grant or award | +586,428 | 7,358,706 | ||
| 2018-01-01 | Hoenlein Malcolm Director | Grant or award | +50,000 | 285,000 | ||
| 2018-01-01 | Harvey Jimmie Director | Grant or award | +100,000 | 450,000 |
Page 7 of 12 · 231 trades